Literature DB >> 14275709

TREATMENT OF CHRONIC BRONCHITIS WITH AMPICILLIN: SOME PHARMACOLOGICAL OBSERVATION.

J R MAY, D M DELVES.   

Abstract

Entities:  

Keywords:  AMPICILLIN; BIOLOGICAL ASSAY; BRONCHITIS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY; HAEMOPHILUS INFLUENZAE; PHARMACOLOGY; SPUTUM

Mesh：

Substances：

Year:  1965        PMID： 14275709     DOI： 10.1016/s0140-6736(65)91253-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  31 in total

1.  Absorption of ampicillin from the human lung.

Authors:  J L Maddocks
Journal:  Thorax       Date:  1975-02       Impact factor: 9.139

Review 2.  Pulmonary disposition of antimicrobial agents: methodological considerations.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

Review 3.  Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

4.  Cefuroxime: pharmacokinetic study in bronchial secretions.

Authors:  E Bergogne-Berezin; P Even; G Berthelot; J Pierre
Journal:  Proc R Soc Med       Date:  1977

5.  5-fluorocytosine and amphotericin B in bronchial secretions.

Authors:  J E Pennington; E R Block; H Y Reynolds
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

6.  Absorption of phenol red from the human lung.

Authors:  J L Maddocks
Journal:  Thorax       Date:  1975-06       Impact factor: 9.139

7.  Penetration of ampicillin and sulbactam in the lower airways during respiratory infections.

Authors:  Y J Valcke; M T Rosseel; R A Pauwels; M G Bogaert; M E Van der Straeten
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

8.  Serum and sputum antibiotic levels after ampicillin, amoxycillin and bacampicillin chronic bronchitis patients.

Authors:  B Davies; F Maesen
Journal:  Infection       Date:  1979       Impact factor: 3.553

9.  Anti-Pseudomonas activity in bronchial secretions of patients receiving amikacin or tobramycin as a continuous infusion.

Authors:  G Mombelli; L Coppens; J P Thys; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

10.  Induction of L forms of Haemophilus influenzae in culture and their demonstration in human bronchial secretions.

Authors:  E M Lapinski; E D Flakas
Journal:  J Bacteriol       Date:  1967-04       Impact factor: 3.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.